Uwe Reinhardt - Tekla Healthcare Independent Trustee
| XHQHX Fund | USD 18.66 0.06 0.32% |
Dr. Uwe E. Reinhardt, Ph.D., is an Independent Trustee of HQ Healthcare Investors. Dr. Reinhardt is the James Madison Professor of Political Economy at Princeton University, teaching economics and public affairs since 1968, and was a member of the Institute of Medicine of the National Academy of Sciences since 1978. He serves on the Audit Committee of each Fund. Dr. Reinhardt is recognized as one of the nation leading authorities on health care economics, a prominent scholar in health care economics and a frequent speaker and author on subjects ranging from the war in Iraq to the future of Medicare. Dr. Reinhardt provides each Fund with valuable insights in healthcare economics and reform. He is a past president of the Association of Health Services Research. From 1986 to 1995 he served as a commissioner on the Physician Payment Review Committee, established in 1986 by Congress to advise it on issues related to the payment of physicians. He is a senior associate of the Judge Institute for Management of Cambridge University, UK, and a trustee of Duke University and the Duke University Health System. Dr. Reinhardt is or was a member of numerous editorial boards, among them the Journal of Health Economics, the Milbank Memorial Quarterly, Health Affairs, the New England Journal of Medicine, and the Journal of the American Medical Association
| Age | 79 |
| Tenure | 36 years |
| Professional Marks | Ph.D |
Similar Money Managers
| Showing other executives | One Year Return | ||
| Charles Bardelis | John Hancock Financial | 79 | |
| Valerie Mosley | Eaton Vance Tax | 61 | |
| Lauren CFA | Royce Value Closed | N/A | |
| Craig Bromley | John Hancock Financial | 50 | |
| Dr MS | Tekla Healthcare Investors | 71 | |
| William Reardon | Tekla Life Sciences | 74 | |
| Mark Fetting | Eaton Vance Tax | 67 | |
| George Gorman | Eaton Vance Tax | 69 | |
| Peter Branner | Tekla Life Sciences | N/A | |
| Rakesh Jain | Tekla Healthcare Investors | 69 | |
| Laura Woodward | Tekla Healthcare Investors | 51 | |
| Cynthia Frost | Eaton Vance Tax | 60 | |
| Laura Woodward | Tekla Healthcare Opportunities | 51 | |
| Marianne Harrison | John Hancock Financial | 57 | |
| Helen Peters | Eaton Vance Tax | 73 | |
| Scott Wennerholm | Eaton Vance Tax | 62 | |
| Warren Thomson | John Hancock Financial | 64 | |
| Peter Hoglund | Royce Value Closed | 54 | |
| Salvatore Schiavone | John Hancock Financial | 55 | |
| Scott Eston | Eaton Vance Tax | 60 | |
| Neil Bloom | Cohen And Steers | 44 | |
Tekla Healthcare Inv Leadership Team
Elected by the shareholders, the Tekla Healthcare's board of directors comprises two types of representatives: Tekla Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tekla. The board's role is to monitor Tekla Healthcare's management team and ensure that shareholders' interests are well served. Tekla Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tekla Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Kent, Independent Trustee | ||
| William Reardon, Independent Trustee | ||
| Michael Bonney, Independent Trustee | ||
| Elizabeth Nabel, Independent Trustee | ||
| Oleg Pohotsky, Independent Chairman of the Board of Trustees | ||
| Laura Woodward, Chief Compliance Officer, Treasurer, Secretary | ||
| Lucinda Stebbins, Independent Trustee | ||
| Daniel Omstead, President Trustee | ||
| Uwe Reinhardt, Independent Trustee | ||
| Rakesh Jain, Independent Trustee |
Tekla Fund Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right mutual fund is not an easy task. Is Tekla Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tekla Healthcare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tekla Healthcare's short interest history, or implied volatility extrapolated from Tekla Healthcare options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Tekla Healthcare Investors. Also, note that the market value of any mutual fund could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Tekla Healthcare Inv information on this page should be used as a complementary analysis to other Tekla Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.